Web2 set 2024 · For patients with bulky N2 and PAN metastases, the 3-year and 5-year OS rates were 7.4% and 0.0%, respectively, which were lower than those of the JCOG0405 study (20.0% and 20.0%). Conclusion The results of our study suggest that D2 lymphadenectomy alone is suitable for GC patients with only bulky N2 metastasis after … Web5 mar 2024 · JCOG conducted another phase II study to evaluate the efficacy and safety of the preoperative chemotherapy with S-1 + cisplatin, which was the same regimens as …
A phase II study of preoperative chemotherapy with docetaxel
WebJCOG0210 included patients with linitis plastica and large ulcero-invasive tumors, whereas JCOG0405 comprised those with para-aortic or bulky lymph node metastases. Radiologic evaluations were conducted using RECIST in JCOG0405 and JCGC criteria in JCOG0210, because the latter included many patients without measurable lesions. WebThe pathological RR defined as residual tumor corresponding to less than one-third the size of the original tumor was 34.6% in 52 eligible patients, which was slightly higher than in JCOG0405 (28.6%). Among all eligible patients, 5-year overall survival was 54.9% (95% confidence interval 40.3–67.3%) at the date cut-off of May 2024. jessica mitchell facebook
randomized Phase II trial of systemic chemotherapy with and …
Webjcog0405： 高度リンパ節転移を伴う進行胃がんに対する術前s-1+cddp併用療法 + 外科切除の第Ⅱ相臨床試験 [ 作成年月日 ] 2012.10.16 研究事務局：円谷 彰 神奈川県立がんセン … Web1 feb 2011 · This study is conducted to explore if survival is still better in JCOG0405 after adjusting baseline factors and if there is a subset of patients (pts) who benefit more from either treatment. Web3 set 2013 · JCOG0405 trial because barium X-rays and endoscopic. examinations were not performed after neoadjuvant. chemotherapy. Validity of response criteria in gastric cancer 515. 123. jessica m jones hempstead ny